Lab-Grown immune organoids could unlock secrets of Kids' cancers

NCT ID NCT05890781

Recruiting now Knowledge-focused Sponsor: Gustave Roussy, Cancer Campus, Grand Paris Source: ClinicalTrials.gov ↗

First seen Feb 12, 2026 · Last updated Jun 07, 2026 · Updated 16 times

Summary

This study aims to create immune organoids—tiny lab-grown models of the immune system—using cells from children and young adults with brain tumors, kidney tumors, neuroblastoma, or sarcoma. Researchers will mix these organoids with tumor cells to see how they interact. The goal is to better understand these cancers, not to treat them directly. About 108 participants will provide tissue samples for this research.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Gustave Roussy
RECRUITING

Villejuif, 94805, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Hopital Necker
RECRUITING

Paris, Île-de-France Region, 75015, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

BRAIN TUMOR KIDNEY TUMOR NEUROBLASTOMA NEUROBLASTOMA SARCOMA